Category: Health

JDRF New Logo

JDRF Funded Researchers Test Topical Drug to Treat Diabetic Macular Edema

The Juvenile Diabetes Research Foundation (JDRF) announced that researchers at the Wilmer Eye Institute of Johns Hopkins University School of Medicine in Maryland completed a multicenter human clinical trial treating diabetic macular edema with mecamylamine, a topical drug developed by the biotech company CoMentis, Inc. Funding for the study was provided by JDRF through its Industry Drug Development Partnership program...
0 Shares

Preventable Risk Factors Reduce Life Expectancy in US

A new study, published online by PLoS Medicine, estimates that smoking, high blood pressure, elevated blood glucose, and obesity currently reduce life expectancy in the U.S. by 4.9 years in men and 4.1 years in women. It is the first study to look at the effects of those four preventable risk factors on life expectancy in the whole nation...
0 Shares

What is LADA?

A form of diabetes characterized by age, a lack of family history of type 2, a gradual increase in insulin requirements, positive antibodies, and decreasing ability to make insulin...
0 Shares

Blood Pressure Drug Reduces Risk Of Cardiovascular Disease and Stroke

According to a press release by the AHA, a new study published in Hypertension: Journal of the American Heart Association has shown that a long-acting ACE inhibitor used to reduce blood pressure significantly decreased the risk for cardiovascular disease, including stroke, in normal weight, overweight and obese patients....
0 Shares

Gestational Diabetes Diagnosed at Lower Blood Glucose Levels

A new international study involving 23,000 women in nine countries suggests that more than twice as many mothers to be as previously thought will develop gestational diabetes. This finding is based on new measurements for determining dangerous blood sugar levels for the mother and her unborn baby. Previous guidelines to diagnose gestational diabetes were based on blood sugar levels that identified women...
0 Shares
Amylin logo

Amylin and Takeda Advance Development of New Obesity Treatment

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin) and metreleptin (an analog of the natural hormone leptin)...
0 Shares

IOM Report Declares High Blood Pressure a Neglected Disease

According to a new report by the Institute Of Medicine, high blood pressure is a neglected disease in the United States. The report calls for strategies to change Americans' lifestyles and diets to curb hypertension. High blood pressure or hypertension is easily preventable through diet, exercise and drugs, yet it is the second-leading cause of death in the United States, said committee chair.
0 Shares